Home › Swiss drug maker Novartis says Q3 net income drops following sale of shares to Merck last year
 

Keywords :   


Swiss drug maker Novartis says Q3 net income drops following sale of shares to Merck last year

2015-10-27 12:55:47| Biotech - Topix.net

Swiss pharmaceutical giant Novartis says net income fell 42 per cent in the third quarter, largely due to the sale of its hepatitis drug unit a year earlier and provisions for legal settlements and fees. The company says the integration of businesses from a multibillion-dollar product exchange with rival GlaxoSmithKline earlier this year is on track.

Tags: to net year sale

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
28.06Tropical Depression Two Forecast Discussion Number 1
28.06Tropical Depression Two Wind Speed Probabilities Number 1
28.06Cattle producers celebrate Supreme Court decision to rein in administrative overreach
28.06Diversified Labeling Solutions expands RFID capabilities
More »